Karbontetraklorid ($CCI_4$) ile deneysel olarak karaciğer nekrozu oluşturulan ratlarda vitamin E+selenyum ve Nigella sativa (Çörekotu)

Bu çalışmada, ratlarda karbontetraklorid (CC14) ile deneysel oluşturulan karaciğer nekrozunun engellenmesinde Nigella sativa (çörekotu)'nın etkisi araştırıldı. Çörekotunun antioksidan etkisinin karşılaştırılabilmesi amacıyla, yaygın olarak antioksidan amaçla kullanılan vitamin E ve selenyum elementi seçildi. Denemede 40 adet rat kullanıldı ve her grupta sekiz rat bulunacak şekilde A, B, C, D ve E gruplarına ayrıldı. A grubu kontrol olarak belirlendi ve deneme boyunca intraperitoneal (i.p.) parafın likid, B grubuna i.p. olarak likid parafın içinde CC14, C grubuna i.p. olarak likid parafin içinde CC14 ve i.m. olarak vitamin E + selenyum kombinasyonunun ticari bir preparatı uygulandı. D grubuna i.p. olarak likid parafin içinde CCI4, i.m. olarak vit E + Se preparatı ve standart rat peletine % 10 oranında katılmış çörekotu, E grubuna ise, i.p. olarak likid parafin içinde CCI4 ve standart rat peletine % 10 oranında katılmış çörekotu ad libitum verildi. Tüm gruplardan 4 kez, kontrol grubundakilerden bir de deneme başlangıcında olmak üzere 5 kez kalpten kan alındı ve bu örneklerde Malondialdehid (MDA), Glutasyon peroksidaz (GSH-Px), Süperoksid dismutaz (SOD), Alanin transaminaz (ALT), Aspartat aminotransferaz (AST), Glutasyon (GSH) ve serüloplazmin analizleri yapıldı. B grubunda lipid peroksidasyon ürünlerinin ve antioksidan enzimlerin belirgin bir şekilde arttığı görüldü. En az % ağırlık kaybı E grubunda gözlendi. Karaciğer örneklerinde en az nekroz oranı D grubunda saptandı. Histopatolojik muayene sonuçları da biyokimyasal sonuçlarla tutarlı idi. Sonuç olarak vitamin E + selenyum ve çörekotunun karaciğer nekrozunu engelleyebildiği kanısına varılmıştır.

The effect of Nigella sativa (black seed) and vit. E+selenium in the prevention of liver necrosis experimentally induced with carbon tetrachloride ($CCI_4$) in rats

The preventive effect of Nigella sativa (black seed) was investigated in rats with hepatic necrosis experimentally induced by carbon tetrachloride ($CCl_4$). To compare the antioxidant effect of black seed, well-known antioxidants, vitamin E and selenium mineral, were used. This study was conducted on 40 rats that were divided into five groups of eight. Group A was separated as a control group and treated intraperitoneally (i.p.) with only liquid paraffin. Group B was administered i.p. $CCl_4$ in liquid paraffin. Group C was administered i.p. CCl4 in liquid paraffin and intramuscularly (i.m.) treated with vitamin E + selenium. Group D was administered i.p. $CCl_4$ in liquid paraffin, i.m. treated with vit E + Se and fed ad libitum with standard rat pellets containing 10% black seed. Group E was administered i.p. $CCl_4$ in liquid paraffin and fed ad libitum with standard rat pellets containing 10% black seed. Blood samples were drawn from the heart of the rats four times for the experimental groups and five times for the control group, one of which was at the beginning of the experiment. In blood samples, malondialdehyde (MDA), glutathione peroxidase (GSH-px), superoxide dismutase (SOD), alanine transaminase (ALT), aspartic transaminase (AST), intracellular glutathione (GSH) and ceruloplasmin analyses were performed. In group B blood samples, lipid peroxidation and antioxidant enzymes were significantly increased. The closest enzyme activities to those of the control group were found in group E. The least weight loss percentages were in group E. The least necrosis was detected in the liver samples of group D. Histopathological results were consistent with biochemical results. In conclusion, a liver necrosis preventive effect of vitamin E + selenium and black seed was observed.

___

  • 1- Angell, M., Kassier, J.P.: Alcohol and other drugs-toward a more rational and consistent-policy. N. Engl, J. Med. 1994; 331: 537-539.
  • 2- Steven, E.H., Ned, H.C.: Alcoholism. Scientific American, Inc., 13 Psychiatry, III Alcoholism, 1-12, 1990.
  • 3- Lieber, C.S.: Medical Disorders of Alcoholism. N. Engl. J. Med. 1995:333: 1058-1065.
  • 4- Paradis, V., Kollinger, M., Fabre, M., Holstege, A., Poynard, T., Bedossa, P.: In situ detection of lipid peroxidation by products in chronic liver diseases. Hepatology. 1997: 26: 135.-142.
  • 5- Britton, R.S., Bacon, B.R.: Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology. 1994: 41: 343-348.
  • 6- Kumar, V., Robins, S.L.: Basic Pathology, Fourth ed., W. B. Saunders Company, pp: 587, 1987.
  • 7- Parola, M., Leonarduzzi, G., Biasi, F., Albano, E., Biocca, M.E., Poli, G., Dianzani, M.U.: Vitamin E Dietary Supplementation Protects against Carbon Tetrachloride-lnduced Chronic Liver Damage and Cirrhosis. Hepatology. 1992: 16: 1014-1021.
  • 8- Şanlı, Y.: Veteriner Klinik Farmakoloji ve ilaçla Sağaltım İlkeleri. Özkan Matbaacılık Ltd. ŞU, Ankara, pp: 430, 1999.
  • 9- Sağlam, K., Bakır, B.: Köpeklerin Termal Yanıklarında Antioksidanların Yara iyileşmesi üzerine Etkileri. YYÜ, Sağlık Bilimleri Dergisi. 1999: 5(1-2): 26-37.
  • 10- Lieber, C.S.: Pathogenesis and treatment of liver fibrosis in alcoholics: 1996 update. Dig. Dis. Sci. 1997: 15: 42-46.
  • 11- Dworkin, B.M., Rosenthal, W.S., Stahl, R.E., Panesar, N.K.: Decreased hepatic selenium content in alcoholic cirrhosis. Dig. Dis. Sci. 1988: 33: 1213-1217.
  • 12- Türker, L, Bayrak, A.: Çörekotu (Nigella sativa L.)'nun Sabit ve Uçucu Yağ Kompozisyonunun Araştırılması. Standard, 1997: 430: 128-137.
  • 13- Aqel, M., Shaheen, R.: Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J. Ethnopharm. 1996; 52: 23-26.
  • 14- Mahfouz, M., El-Dakhakhny, M.: Some chemical and pharmacologic properties of the new antiasthmatic drug "nigellone". Pharm. Bull. 1960: 42: 411-415.
  • 15- Hanafy, M.S., Hatem, M.E.: Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J. Indiana State Med. Assoc. 1991:34:275-278.
  • 16- Salomi, N.J., Nair, S.C., Jayawarahanan, K.K., Varghese, CD.: Antitumor principles from Nigella sativa seeds. Johns- Hopkins Alumni. Mag. 1992: 63(1): 33-36.
  • 17- Daba, M.H., Abdel-Rahman, M.S^: Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol. Lett.95(1): 23-29.
  • 18- Beutler, E., Duron, 0., Kelly, B.M.: Improved Method for the Determination of Blood Glutathione. J. Lab. Clin. Med. 1963; 61(5): 882-885.
  • 19- Akkuş, i.: Serbest Radikaller ve Fizyopatolojik Etkileri. Konya, Mimoza Yayınları, 1995.
  • 20- Yenson, M.: Klinik Biyokimya Laboratuvar Çalışmaları, Beta Yayınları, 6. Baskı, istanbul, 1986.
  • 21- Düzgüneş, 0., Kesici, T., Kavuncu, 0., Gürbüz, F.: Araştırma ve Deneme Metotları (İstatistik Metotları-1) Ankara Üniv. Zir. Fak. Yay. No: 1021, Ankara, 1987.
  • 22- Fischer-Nielsen, A., Poulsen, H.E., Hansen, B.A., Hage, E., Keiding, S.: CCI4 cirrhosis in rats: irreversible histological changes and differentiated functional impairment. J. Hepatol. 1991; 12: 110-117.
  • 23- Türkdoğan, M.K., Ağaoğlu, Z.. Yener, Z., Şekeroğlu, R., Akkan, H.A., Avcı, M.E.: The Role of Antioxidant Vitamins (C and E), Selenium and Nigella sativa in the Prevention of Liver Fibrosis and Cirrhosis in Rabbits: New Hopes. Dtsch. Tierartzl. Wschr. 2001; 108: 71-73.
  • 24- Milli, Ü.M., Hazıroğlu, R.: Veteriner Patoloji İl. Cilt, pp: 195, 2000.
  • 25- Müller, G., Rahfeld, B., Tannasch, M.: Malondialdehyde Concentration in Blood Plasma of Patients with Liver Disease. Z. Gesamte. Inn. Med. 1992; 47(6): 263-265.
  • 26- McDonald, CM.: The Effect of Ethanol on Hepatic Lipid Peroxidation and the Activities of Glutathione Reductase and Peroxidase. Febs Letters. 1973; 35 (2): 218-227.
  • 27- French, S.W., Morimoto M., Reitz, R.C, Koop, D., Kiopfenstein, B.. Estes, K., Clot, P. Sundberg, M.A., Albabo, E.: Lipid Peroxidation, CYP2E1 and Arachidonic Acid Metabolism in Alcoholic liver Disase in Rats.J.Nutr.1977:127:907-911.
  • 28- Ichinose, T., Miller, M.G., Shibamoto, T.: Determination of Free Malondyaldehyde Formed in Liver Microsomes upon CCI4 Oxidation. J. Appl. Toxicol. 1994; 14 (6): 453-455.
  • 29- Thresiamma, K.C., Kuttan, R.: Inhibition of liver fibrosis by ellagic acid. Indian J. Physiol. Pharmacol. 1996 ; 40(4): 363-366.
  • 30- Dashti, H., Jeppson, B., Hagerstrand, I., Hultberg, B., Srinivas, U., Abdulla, M., Bengmark, S.: Thioacetamide- and Carbon Tetrachloride-lnduced Liver Cirrhosis. Eur. Surg. Res. 1989 : 21: 83-89.
  • 31- Turgut, K., Demir, C, Ok, M., Çiftçi, M.K.: Ultrasonographic Evaluation of the Liver Damage in the Dog with Carbon Tetrachloride in Toxication. Tr. J. of Veterinary and Animal Sciences. 1995; 19:335-338.
  • 32- Lieber, C.S.: Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv. Pharmacol. 1997b; 38: 601-628.
  • 33- Loginov, A.S., Matiustin, B.N., Chebanov, S.M., Reshetniak, V.I.: Chölestasis Assessment by Activity of Antioxidant'Enzymes and Composition of Plasma Lipoproteins in Patients with Liver Diseases. Ter. Arkh. 1998; 70(4): 40-42.
  • 34. Ritland, S., Steinnes, E., Skrede, S.: Hepatic Copper Content, Urinary Copper Excretion and Serum Ceruloplasmin in Liver Disease. Scan. J. Gastroent. 1983; 12: 81-88.
  • 35- Van Gool, J., De Nie, I., Smit, J., Zuyderhout, F.M.: Mechanis , by Which Acute Phase Proteins Enhance Development of Liver Fibrosis: Effects on Collagenase and Proly-4-Hydroxylase Activjt-' in the Rat Liver. Exp. Mol. Pathol., 1986; 45(2): 160-170